BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 38458580)

  • 1. Risk factors for thrombosis and spontaneous echocardiographic contrast with sludge in atrial fibrillation patients treated with oral anticoagulants before electrical cardioversion.
    Rekosz J; Karwowski J; Kowalik I; Wiktorska A; Wrzosek K; Solecki M; Szmarowska K; Szymańska A; Mierzejewska B; Syska-Sumińska J; Dłużniewski M
    Kardiol Pol; 2024; 82(5):516-526. PubMed ID: 38606742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serum metabolomic profiles of atrial fibrillation patients treated with direct oral anticoagulants or vitamin K antagonists.
    Vignoli A; Gori AM; Berteotti M; Cesari F; Giusti B; Bertelli A; Kura A; Sticchi E; Salvadori E; Barbato C; Formelli B; Pescini F; Marcucci R; Tenori L; Poggesi A
    Life Sci; 2024 Jun; 351():122796. PubMed ID: 38852797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of non-vitamin K oral anticoagulants for thrombosis prophylaxis in pediatric heart diseases.
    Hong H; Zhu W; Xie Z
    Eur J Intern Med; 2024 Jun; 124():138-140. PubMed ID: 38443264
    [No Abstract]   [Full Text] [Related]  

  • 4. Left atrial thrombus and dense spontaneous echocardiographic contrast in patients on continuous direct oral anticoagulant therapy undergoing catheter ablation of atrial fibrillation: Comparison of dabigatran, rivaroxaban, and apixaban.
    Wu M; Gabriels J; Khan M; Shaban N; D'Amato S; Liu CF; Markowitz SM; Ip JE; Thomas G; Singh P; Lerman B; Patel A; Cheung JW
    Heart Rhythm; 2018 Apr; 15(4):496-502. PubMed ID: 29605015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial thrombus detection on transoesophageal echocardiography in patients with atrial fibrillation undergoing cardioversion or catheter ablation: A pooled analysis of rates and predictors.
    Noubiap JJ; Agbaedeng TA; Ndoadoumgue AL; Nyaga UF; Kengne AP
    J Cardiovasc Electrophysiol; 2021 Aug; 32(8):2179-2188. PubMed ID: 33969568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of transesophageal echocardiography findings after different anticoagulation strategies in patients with atrial fibrillation: a systematic review and meta-analysis.
    Yang J; Zhang X; Wang XY; Zhang C; Chen SZ; Hu SJ
    BMC Cardiovasc Disord; 2019 Nov; 19(1):261. PubMed ID: 31771529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis.
    Gupta S; Um KJ; Pandey A; McIntyre WF; Ivanova M; Allahverdi Y; Agahi P; Pandya F; Lopez A; Sachdeva A; Whitlock RP; Belley-Cote EP
    Cardiovasc Drugs Ther; 2019 Jun; 33(3):339-352. PubMed ID: 31011880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial Thrombosis Prevalence Before Cardioversion or Catheter Ablation of Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Vitamin K Antagonists.
    Troisi F; Guida P; Vitulano N; Quadrini F; Di Monaco A; Patti G; Grimaldi M
    Am J Cardiol; 2024 May; 218():77-85. PubMed ID: 38458580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary Management of Direct Oral Anticoagulants During Cardioversion and Ablation for Nonvalvular Atrial Fibrillation.
    Trujillo TC; Dobesh PP; Crossley GH; Finks SW
    Pharmacotherapy; 2019 Jan; 39(1):94-108. PubMed ID: 30548542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe Bleeding Risk of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Stroke Prevention and Treatment in Patients with Atrial Fibrillation: A Systematic Review and Network Meta-Analysis.
    Xu W; Lv M; Wu S; Jiang S; Zeng Z; Fang Z; Qian J; Chen M; Chen J; Zhang J
    Cardiovasc Drugs Ther; 2023 Apr; 37(2):363-377. PubMed ID: 34436708
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.